drugset / Trial / NCT07021859

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

NCT07021859

Recruiting 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.

Timeline

Start
2025-06-27
Primary completion
2026-06-01
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitonin Gene-Related Peptide Peptide 90 ug Intravenous

Indications